Pharma Journalist -

Pfizer Inc. and Eli Lilly and Company announced positive top-line results from a Phase 3 study evaluating tanezumab in patients with moderate-to-severe chronic low back pain (CLBP). In…
Read More...

NEW ORLEANS & Ochsner Health System, Louisiana’s largest non-profit academic healthcare system, and Pfizer Inc have entered into a multi-year strategic alliance to develop…
Read More...

Aucta Pharmaceuticals announced that it has entered into an agreement with Oakrum Pharma, LLC (Oakrum) to develop and manufacture four prescription generic pharmaceutical products that…
Read More...

Exicure, Inc. and Dermelix Biotherapeutics announced a license and development agreement to advance SNA therapeutics in rare genetic skin diseases. Under the terms of agreement,…
Read More...

Industry experts from Amgen and GSK will be presenting on regulatory updates and patient safety on day one of the 2nd annual Injectable Drug Delivery conference in London. The global…
Read More...

STA Pharmaceutical Co., Ltd., (WuXi STA), a subsidiary of WuXi AppTec, and BioLingus, a Swiss biotech company, announce they have formed an exclusive technology and marketing…
Read More...

Genentech announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s Biologics License Application (BLA) and granted Priority Review for polatuzumab vedotin…
Read More...

Genentech announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s New Drug Applications (NDAs) and granted Priority Review for entrectinib for the…
Read More...

Eli Lilly and Company announced the successful completion of its acquisition of Loxo Oncology. The acquisition broadens the scope of Lilly's oncology portfolio into precision medicines…
Read More...

Innovent Biologics announced the signing of a collaboration agreement with Shenzhen Chipscreen Biosciences Co., Ltd. (Chipscreen Biosciences) to evaluate the safety and tolerability of…
Read More...